Breast Cancer Prevention Trial shows major benefit, some risk

doi:10.1093/jnci/90.9.647

JNCI Journal of the National Cancer Institute 1998 90(9):647-648; doi:10.1093/jnci/90.9.647
© 1998 by Oxford University Press

This Article

	Full Text
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Personal Archive
	Download to citation manager
	Request Permissions

Google Scholar

	Articles by Smigel, K.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Smigel, K.

Social Bookmarking

	What's this?

Breast Cancer Prevention Trial Shows Major Benefit, Some Risk

Initial results of the Breast Cancer Prevention Trial were released last month when women at increased risk of breast cancer who were taking tamoxifen were found to have a 45% reduction in breast cancer incidence compared to women on a placebo. More than 13,000 women had been randomly assigned to either tamoxifen or a placebo; the women on tamoxifen had 85 cases of invasive breast cancer compared . . . [Full Text of this Article]

Add to CiteULike CiteULike Add to Connotea Connotea Add to Del.icio.us Del.icio.us What's this?

This article has been cited by other articles:

A. K. C. Teo, H. K. Oh, R. B. Ali, and B. F. L. Li
The Modified Human DNA Repair Enzyme O6-Methylguanine-DNA Methyltransferase Is a Negative Regulator of Estrogen Receptor-Mediated Transcription upon Alkylation DNA Damage
Mol. Cell. Biol., October 15, 2001; 21(20): 7105 - 7114.
[Abstract] [Full Text] [PDF]

A. P. Brown, R. L. Morrissey, T. A. Tolhurst, J. A. Crowell, and B. S. Levine
Oral Toxicity of 1,2-Dithiole-3-Thione, a Potential Cancer Chemopreventive Agent, in the Rat
International Journal of Toxicology, November 1, 2000; 19(6): 375 - 381.
[Abstract] [PDF]

K. El Abdaimi, N. Dion, V. Papavasiliou, P.-E. Cardinal, L. Binderup, D. Goltzman, L.-G. Ste-Marie, and R. Kremer
The Vitamin D Analogue EB 1089 Prevents Skeletal Metastasis and Prolongs Survival Time in Nude Mice Transplanted with Human Breast Cancer Cells
Cancer Res., August 1, 2000; 60(16): 4412 - 4418.
[Abstract] [Full Text]

A. Bollig and R. J. Miksicek
An Estrogen Receptor-{alpha} Splicing Variant Mediates Both Positive and Negative Effects on Gene Transcription
Mol. Endocrinol., May 1, 2000; 14(5): 634 - 649.
[Abstract] [Full Text]

C. M. Cover, S. J. Hsieh, E. J. Cram, C. Hong, J. E. Riby, L. F. Bjeldanes, and G. L. Firestone
Indole-3-Carbinol and Tamoxifen Cooperate to Arrest the Cell Cycle of MCF-7 Human Breast Cancer Cells
Cancer Res., March 1, 1999; 59(6): 1244 - 1251.
[Abstract] [Full Text] [PDF]

				A. P. Brown, R. L. Morrissey, T. A. Tolhurst, J. A. Crowell, and B. S. Levine Oral Toxicity of 1,2-Dithiole-3-Thione, a Potential Cancer Chemopreventive Agent, in the Rat International Journal of Toxicology, November 1, 2000; 19(6): 375 - 381. [Abstract] [PDF]

				K. El Abdaimi, N. Dion, V. Papavasiliou, P.-E. Cardinal, L. Binderup, D. Goltzman, L.-G. Ste-Marie, and R. Kremer The Vitamin D Analogue EB 1089 Prevents Skeletal Metastasis and Prolongs Survival Time in Nude Mice Transplanted with Human Breast Cancer Cells Cancer Res., August 1, 2000; 60(16): 4412 - 4418. [Abstract] [Full Text]

				A. Bollig and R. J. Miksicek An Estrogen Receptor-{alpha} Splicing Variant Mediates Both Positive and Negative Effects on Gene Transcription Mol. Endocrinol., May 1, 2000; 14(5): 634 - 649. [Abstract] [Full Text]

				C. M. Cover, S. J. Hsieh, E. J. Cram, C. Hong, J. E. Riby, L. F. Bjeldanes, and G. L. Firestone Indole-3-Carbinol and Tamoxifen Cooperate to Arrest the Cell Cycle of MCF-7 Human Breast Cancer Cells Cancer Res., March 1, 1999; 59(6): 1244 - 1251. [Abstract] [Full Text] [PDF]